Li He
Lawyers
Filters
JOINN Laboratories HK$6.5 billion IPO
We advised JOINN Laboratories on its IPO and HKEX listing.
Youdao $238 million equity follow-on offering
We advised Youdao on its offering of ADSs
Adagene $161 million IPO
We advised Adagene on its IPO and Nasdaq listing
Kuke Music Holding $50 million IPO and NYSE listing
We advised the underwriters on the IPO of ADSs
iQIYI $1.5 billion concurrent convertible notes and equity offerings
Davis Polk advised the joint book-running managers in connection with concurrent SEC-registered offerings by iQIYI, Inc. of $800 million aggregate principal amount of its 4.00%…
Pop Mart HK$5.2 billion IPO and Hong Kong listing
Davis Polk advised Pop Mart International Group Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance…
RemeGen HK$4 billion Hong Kong IPO
Davis Polk advised the underwriters in the initial public offering of RemeGen Co., Ltd. on the Hong Kong Stock Exchange and an international offering and listing in reliance on Rule 144A…
JW (Cayman) Therapeutics HK$2.33 billion Hong Kong IPO
Davis Polk advised the underwriters in the initial public offering of JW (Cayman) Therapeutics Co. Ltd on the Hong Kong Stock Exchange and an international offering and listing in reliance…
Meituan $2 billion debut senior notes offering
Davis Polk advised the initial purchasers in connection with the Rule 144A/Regulation S offering by Meituan of $750 million 2.125% senior notes due 2025 and $1.25 billion 3.050% senior…
DouYu International Holdings merger with HUYA
Davis Polk is advising DouYu International Holdings Limited in connection with its stock-for-stock merger with HUYA Inc. Upon closing of the transaction, Huya will acquire all the…